236 related articles for article (PubMed ID: 1376704)
1. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
Corbett JA; Tilton RG; Chang K; Hasan KS; Ido Y; Wang JL; Sweetland MA; Lancaster JR; Williamson JR; McDaniel ML
Diabetes; 1992 Apr; 41(4):552-6. PubMed ID: 1376704
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide formation by guanidines.
Hasan K; Heesen BJ; Corbett JA; McDaniel ML; Chang K; Allison W; Wolffenbuttel BH; Williamson JR; Tilton RG
Eur J Pharmacol; 1993 Nov; 249(1):101-6. PubMed ID: 7506664
[TBL] [Abstract][Full Text] [Related]
4. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
[TBL] [Abstract][Full Text] [Related]
8. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion.
Corbett JA; Lancaster JR; Sweetland MA; McDaniel ML
J Biol Chem; 1991 Nov; 266(32):21351-4. PubMed ID: 1657959
[TBL] [Abstract][Full Text] [Related]
11. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
Xenos ES; Stevens RB; Gores PF; Casanova D; Farney AC; Sutherland DE; Platt JL
Transplant Proc; 1993 Feb; 25(1 Pt 2):994. PubMed ID: 7680174
[No Abstract] [Full Text] [Related]
12. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
[TBL] [Abstract][Full Text] [Related]
13. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide.
Corbett JA; Kwon G; Turk J; McDaniel ML
Biochemistry; 1993 Dec; 32(50):13767-70. PubMed ID: 7505613
[TBL] [Abstract][Full Text] [Related]
14. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo.
Laszlo F; Evans SM; Whittle BJ
Eur J Pharmacol; 1995 Jan; 272(2-3):169-75. PubMed ID: 7536162
[TBL] [Abstract][Full Text] [Related]
15. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
Laychock SG; Modica ME; Cavanaugh CT
Endocrinology; 1991 Dec; 129(6):3043-52. PubMed ID: 1683279
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
Griffiths MJ; Messent M; MacAllister RJ; Evans TW
Br J Pharmacol; 1993 Nov; 110(3):963-8. PubMed ID: 7507781
[TBL] [Abstract][Full Text] [Related]
17. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
[TBL] [Abstract][Full Text] [Related]
18. Effects of endothelin-1 and inhibition of nitric oxide production with NG-monomethyl-L-arginine on arterial pressure and regional blood flow in anesthetized rats.
Takahashi H; Nakanishi T; Nishimura M; Tanaka H; Yoshimura M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S176-8. PubMed ID: 1282961
[TBL] [Abstract][Full Text] [Related]
19. Effects of guanidino and uremic compounds on nitric oxide pathways.
MacAllister RJ; Whitley GS; Vallance P
Kidney Int; 1994 Mar; 45(3):737-42. PubMed ID: 7515129
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
